Cardura Medication Summary
No separate FDA Medication Guide was found for this label. This summary is based on FDA/DailyMed prescribing information.
What is this medication?
This medication is described in FDA/DailyMed prescribing information. No separate FDA Medication Guide was found for this label. This summary is based on FDA/DailyMed prescribing information.
What is this medication used for?
Doxazosin tablets are an alpha 1 adrenergic antagonist indicated for: Signs and symptoms of Benign Prostatic Hyperplasia (BPH)Treatment of HypertensionTreatment of Hypertension
What should I know before taking it?
The use of doxazosin tablets is contraindicated in patients with a hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any of its components.
What important warnings are listed?
Postural hypotension with or without syncope may occur. ( 5.1) Risk of Intraoperative Floppy Iris Syndrome during cataract surgery. ( 5.2) Screen for the presence of prostate cancer prior to treatment for BPH and at regular intervals afterwards. ( 5.3)
How is this medication usually taken?
Doxazosin Tablets, USP are available as 1 mg (white to off-white, round, scored tablets, imprinted "APO" on one side and "093" with a partial bisect on the other side), 2 mg (white to off-white, capsule shaped, scored tablets, imprinted "APO" on one side and "094" with a partial bisect on the other side), 4 mg (white to off-white, capsule shaped, scored tablets, imprinted "APO" on one side and "095" with a partial bisect on the other side) and 8 mg (white to off-white, capsule shaped, scored tablets, imprinted "APO" on one side and "096" with a partial bisect on the other side).
What side effects are listed?
The most commonly reported adverse reactions from clinical trials are Fatigue, malaise, hypotension, and dizziness. ( 6.1) To report SUSPECTED ADVERSE REACTIONS, contact contact AvKARE at 1-855-361-3993 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
What interactions are listed?
Strong cytochrome P450 (CYP) 3A inhibitors may increase exposure to doxazosin and increased risk of hypotension. ( 7.1) Concomitant administration of doxazosin tablets with a phosphodiesterase-5 (PDE-5) inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension. ( 7.2)
Where can I find the official prescribing information?
Review the full prescribing information on DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de9ab9a4-d8b8-8b36-e053-2a95a90aaa35
⚠️ Disclaimer
This summary is for educational purposes only and is not medical advice. Always consult your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine. Read full medical disclaimer.